Pharmather Financial Statements From 2010 to 2024
| PHRRF Stock | USD 0.16 0.01 5.88% |
Check Pharmather Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmather Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . Pharmather financial statements analysis is a perfect complement when working with Pharmather Holdings Valuation or Volatility modules.
Pharmather |
Pharmather Holdings OTC Stock Return On Equity Analysis
Pharmather Holdings' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pharmather Holdings Return On Equity | -0.63 |
Most of Pharmather Holdings' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmather Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Pharmather Holdings has a Return On Equity of -0.6321. This is 97.36% lower than that of the Healthcare sector and 98.27% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 103.9% higher than that of the company.
Pharmather Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharmather Holdings's current stock value. Our valuation model uses many indicators to compare Pharmather Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharmather Holdings competition to find correlations between indicators driving Pharmather Holdings's intrinsic value. More Info.Pharmather Holdings is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharmather Holdings' earnings, one of the primary drivers of an investment's value.About Pharmather Holdings Financial Statements
Pharmather Holdings stakeholders use historical fundamental indicators, such as Pharmather Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although Pharmather Holdings investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pharmather Holdings' assets and liabilities are reflected in the revenues and expenses on Pharmather Holdings' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pharmather Holdings. Please read more on our technical analysis and fundamental analysis pages.
PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company was incorporated in 2019 and is headquartered in Toronto, Canada. Pharmather Hldgs is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Pharmather OTC Stock
Pharmather Holdings financial ratios help investors to determine whether Pharmather OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmather with respect to the benefits of owning Pharmather Holdings security.